JNJ Earnings

Upcoming earnings date and last 8 quarters of EPS surprise.

Next Earnings

Jul 15, 2026
36 days ago

EPS Surprise — Last 8 Quarters

Quarterly Detail

QuarterReport DateEst EPSActual EPSSurprise %Result
Q1 2026Apr 14, 20262.682.70+0.85%
Inline
Q4 2025Jan 21, 20262.462.46-0.11%
Inline
Q3 2025Oct 14, 20252.762.80+1.49%
Beat
Q2 2025Jul 16, 20252.682.77+3.21%
Beat
Q1 2025Apr 15, 20252.582.77+7.38%
Beat
Q4 2024Jan 22, 20252.012.04+1.38%
Beat
Q3 2024Oct 15, 20242.212.42+9.71%
Beat
Q2 2024Jul 17, 20242.702.82+4.31%
Beat

Recent Guidance Mentions (8-K)

  • Apr 14, 2026 · 8-K

    com Investor contact: investor-relations@its.jnj.com For immediate release Johnson & Johnson reports Q1 2026 results, raises 2026 outlook • 2026 First-Quarter reported sales growth of 9.9% to $24.1 Billion with operational growth of 6.

    View 8-K filing →
  • Apr 14, 2026 · 8-K

    Growth was driven primarily by electrophysiology products, Abiomed, and Shockwave in Cardiovascular, as well as trauma in Orthopaedics. Full-year 2026 guidance: Johnson & Johnson does not provide GAAP financial measures on a forward-looking basis because the company is unable to predict with reasonable certainty the ultimate outcome o

    View 8-K filing →
  • Apr 14, 2026 · 8-K

    items, are non-GAAP financial measures and should not be considered replacements for, and should be read together with, the most comparable GAAP financial measures. Except for guidance measures, reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying financial schedules of t

    View 8-K filing →

Data updated May 25, 2026 · source: Yahoo Finance via yfinance